相关实验视频
Updated: Jan 18, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.9K
普遍的状固定药物喷发:一个系统的审查
Li Yang Loo1, Nerice Ngiam2, Rehena Sultana3
1Department of Dermatology, Division of Medicine, Singapore General Hospital, Singapore.
The journal of allergy and clinical immunology. In practice
|January 15, 2026
概括
泛性突固定药物喷发 (GBFDE) 是一种严重的反应,通常由NSAID和抗生素引发. 虽然不像SJS/TEN那样严重,但GBFDE具有显著的死亡率,特别是在老年人中.
科学领域:
- 皮肤病学 皮肤病学
- 药物监督 药物监督 药物监督
- 内部医学 内部医学
背景情况:
- 泛型突固定药物喷发 (GBFDE) 是一种严重的皮肤不良反应 (SCAR),具有潜在的危及生命的后果.
- 尽管与史蒂文斯-约翰逊综合征/有毒表皮解 (SJS/TEN) 有相似之处,但GBFDE缺乏全面的特征.
研究的目的:
- 系统地审查GBFDE的流行病学,致病原体,临床特征,组织学,结果和管理.
- 根据现有文献提供GBFDE的全面概述.
主要方法:
- 系统审查遵循系统审查和元分析 (PRISMA) 准则的首选报告项目.
- 搜索了PubMed和Embase数据库 (1985年10月2024年) 查找GBFDE的原始观察病例与定量数据.
- 使用纽卡斯尔-太华尺度评估研究质量,并进行描述性和比较性分析.
主要成果:
- 包括83项研究,430例GBFDE病例;中位数年龄56岁.
- 常见的触发因素:非类固醇抗炎药物 (NSAIDs,48.7%) 和抗生素 (30.9%);中位延迟时间为24小时.
- 死亡率为15.2%,与年龄显著相关;中位数解脱时间为11天;后炎性多色素变异常见 (54.3%).
结论:
- GBFDE表现出短暂的延迟,NSAIDs和抗生素是常见的触发因素.
- 系统性参与比SJS/TEN少,但患病率和死亡率显著,特别是在老年人中.
- 无处方NSAIDs的可用性代表了GBFDE的潜在公共卫生风险.
相关概念视频
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Drug Dosage Regimen: Overview
4.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.4K
Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528

